Akbar Shafiee
MD, MSc
Tehran, Iran
Community medicine specialist
Master of science in vitality and aging
Medical research advisor
Akbar Shafiee
MD, MSc
Tehran, Iran
Community medicine specialist
Master of science in vitality and aging
Medical research advisor
Research
Education
Workshops
- 12 years of clinical research
- Leiden university graduate
- Lecturer of workshops on research methodology & scientific writing
Latest blog posts
New Evidence on Polypill: from CVD Risk Factor Control to Mortality Reduction
The polypill is actually a pill that contains a combination of various drugs commonly used to treat heart disease, dyslipidemia and high blood pressure. Recently,
The benefit of daily Aspirin for high-risk patients
Daily aspirin may benefit some high-risk people without cardiovascular disease (CVD), according to an individualized benefit-harm analysis in the Annals of Internal Medicine. Roughly 250,000 adults
Tehran Thrombosis Congress: Call for Abstract
The Tehran Thrombosis Congress 2019 will be held in Tehran Heart Center on November 21-22, 2019 in Tehran, Iran. The congress is aimed at cardiologists, pulmonologists, internal
Better Cardiovascular Health Reduces the Risk of Dementia
The American Heart Association’s Life’s Simple 7 cardiovascular (CV) score comprises four behavioral measures (smoking, diet, exercise, and body-mass index) and three biological measures (fasting glucose level,
Socioeconomic inequalities affect the use of hypertension and type 2 diabetes management services
Socioeconomic inequalities have a significant impact on the utilisation of hypertension and type 2 diabetes (T2D) management services in the Indonesian population, as well as
Intensive Hypertension Treatment at discharge Increases the Risk of Complications in the elderly
Intensifying antihypertensive regimens of older adults who were hospitalized for noncardiac conditions is associated with several harms and doesn’t appear to reduce cardiovascular events, a JAMA